Nuvectis Pharma Growth Metrics (2022-2026) | NVCT

Growth Metrics Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Enterprise Value Growth (1y) (Quarter) 7.19%-81.26%6.51%-25.57%26.36%22.31%-53.62%-47.90%-106.43%16.05%
Enterprise Value Growth (3y) (Quarter) -21.43%-25.45%-14.45%-17.43%
Enterprise Value (QoQ) (Quarter) -190.84%18.73%-74.18%-58.71%10.16%6.93%5.23%10.39%-32.28%10.74%20.65%
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.00
Return on Assets Growth (3y) (Quarter) 0.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) 3,235.00-3951.00-2879.00-4972.00-2671.00-2520.00-4988.00-5234.003,014.004,213.004,251.008,350.00-2424.00
Return on Capital Employed Growth (3y) (Quarter) 3,578.00-2258.00-3616.00-1856.00-2081.00
Return on Capital Employed (QoQ) (Quarter) 7,224.00423.00-1918.00-2494.0038.001,495.00-4011.00-193.00189.00-973.00-4257.008,056.001,388.00-935.00-158.00-2719.00
Return on Equity Growth (1y) (Quarter) -2.007.000.000.000.000.000.000.000.000.000.000.001.000.00
Return on Equity Growth (3y) (Quarter) -3.008.000.000.000.000.00
Return on Equity (QoQ) (Quarter) -10.008.000.000.000.000.000.000.000.000.000.000.001.000.000.000.000.00